Benicar FDA Warning
In 2013, the FDA warned that the blood pressure drug olmesartan medoxomil manufactured by Japan based Daiichi Sankyo (marketed in the US by Forest Laboratories as Benicar) can cause intestinal problems known as sprue-like enteropathy. The FDA also approved changes to the labels of these drugs to include the risk of developing sprue-like enteropathy while using the drug. However, there has never been a recall of Benicar by the FDA because of its potential link to sprue-like enteropathy.
Benicar Side Effects
Mayo Clinic researchers found a connection between the development of sprue-like enteropathy and Benicar use in a study of almost two dozen patients. Many of those affected by Benicar use lost significant amounts of weight to the point of malnourishment, and had to be hospitalized. The intestinal problems were initially diagnosed as Celiac Disease but the patients’ symptoms did not improve with a prescribed gluten-free diet. It was only upon the discontinuation of Benicar use that all of the patients experienced relief of their gastrointestinal problems. However, the FDA was quick to warn that patients should not stop their use of Benicar without first discussing it with a healthcare professional. If you or a loved one has taken the blood pressure drug Benicar and experienced the following, please call our firm:
- Severe chronic diarrhea
- Significant weight loss
- Villous Atrophy (Overall Malnutrition)
AFFECTED BY BENICAR?
You May Be Entitled to Compensation. Call Now!
Are You Eligible for a Benicar Lawsuit?
The Feeney Law Firm is committed to seeking justice for those affected by Benicar. Fighting to keep people safe from corporate greed and self-interest is our passion. We are here to help make that process as simple as possible for you and your family. Call us now at 1-800-809-0911 for a FREE consultation. Don’t wait; your time to file a Benicar lawsuit may be limited.
Do not stop taking these drugs without first speaking to your doctor.